Tin tức & Cập nhật
Xem bài viết Dược
Xem
Post-exposure PIP comparable to PrEP for low-risk HIV, but more affordable
Post-exposure prophylaxis-in-pocket (PIP) appears as effective as pre-exposure prophylaxis (PrEP) in improving quality of life (QoL) of individuals at low risk for HIV but may be a less costly option, according to a matched-control study presented at CROI 2026.
Post-exposure PIP comparable to PrEP for low-risk HIV, but more affordable
17 Apr 2026
Silymarin plus lifestyle change improves liver health in NAFLD patients with MetS
Silymarin therapy combined with lifestyle interventions can reduce and normalize liver enzyme levels in patients with nonalcoholic fatty liver disease (NAFLD) and associated metabolic syndrome (MetS), a recent study has shown.
Silymarin plus lifestyle change improves liver health in NAFLD patients with MetS
16 Apr 2026
Gotistobart a chemo-free option for metastatic sqNSCLC
Gotistobart monotherapy elicits an improved and durable antitumour response with a meaningful survival benefit relative to docetaxel in patients with metastatic squamous nonsmall cell lung cancer (sqNSCLC) who experience disease progression on or after anti-PD-(L)1 treatment, as shown by the results of the stage 1 PRESERVE-003 phase III trial.
Gotistobart a chemo-free option for metastatic sqNSCLC
15 Apr 2026
Mavacamten reduces blood flow obstruction in adolescents with HCM
Treatment with mavacamten, compared with placebo, results in significantly greater reduction in left ventricular outflow tract (LVOT) obstruction over 28 weeks among adolescent patients with obstructive hypertrophic cardiomyopathy (HCM), as shown in the SCOUT-HCM trial.
